发明名称 Rapid dissolution formulation of a calcium receptor-active compound
摘要 Disclosed is a pharmaceutical composition comprising a) from about 10% to about 40% by weight of cinacalcet HCl; b) from 40% to about 75% by weight of microcrystalline cellulose; c) from about 1% to about 5% by weight of povidone; d) from about 5% to about 35% by weight of starch; e) from about 1% to about 10% by weight of crospovidone; f) from about 0.05% to about 1.5% by weight of colloidal silicon dioxide; and g) from about 0.05% to about 1.5% by weight of magnesium stearate; wherein the percentage by weight is relative to the total weight of the composition. Also disclosed is the use of the above composition in the manufacture of a medicament for the treatment of hyperparathyroidism, hyperphosphonia, hypercalcemia, and elevated calcium phosphorus product.
申请公布号 NZ545498(A) 申请公布日期 2010.04.30
申请号 NZ20040545498 申请日期 2004.09.10
申请人 AMGEN INC. 发明人 ALVAREZ, FRANCISCO J;LAWRENCE, GLEN GARY;LIN, HUNG-REN H;JU, TZUCHI R
分类号 A61K31/00;A61K9/20;A61K9/28;A61K31/135;A61K31/137;A61P5/18;C07C211/26 主分类号 A61K31/00
代理机构 代理人
主权项
地址